UFP Technologies (UFPT) Stock: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$277.89
0.49 (0.18%)
▲
5d:
-3.01%
30d:
-13.82%
90d:
+16.47%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UFPT is fairly valued with market pricing in 3.5% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: UFPT is fairly valued with market pricing in 3.5% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$365.78
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$227.12
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $277.89, which is considered oversold relative to its 30-day fair value range of $289.38 to $320.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.4) compared to its historical average (21.1). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, UFPT is in a strong uptrend. The price is currently testing key support at $273.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $355.00 (+27.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UFPT is in a strong uptrend. The price is currently testing key support at $273.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $355.00 (+27.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$289.38 -
$320.93
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.7% below Wall St target ($355.00)
- NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$289.38 -
$320.93
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$273.37
Resistance Level
$305.48
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.41
Wall Street Target
$355.00
(+27.7%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
21.3%
Profit Margin
11.5%
Valuation Premium vs History
+3.5% premium
PE vs Historical
23.4 vs 21.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$287.62
(+4%)
2-Year Target
$297.68
(+7%)
3-Year Target
$308.10
(+11%)
3-Yr Target (if PE normalizes)
(PE: 23→21)
PE COMPRESSION
$277.74
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.4, Growth: 11.8%)
$388.26
(+40%)
Base:
(SPY PE: 20.2, Growth: 11.8%)
$334.58
(+20%)
Bear:
(PE: 17.1, Growth: 11.8%)
$284.39
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 30.12 | Current EPS (TTM): $9.21
Bull Case
$393.35
(+42%)
Analyst growth 28.9%, PE expands to 33.1
Base Case
$357.59
(+29%)
Market implied 28.9%, PE stable at 30.1
Bear Case
$188.63
(-32%)
Severe decline -20.0%, PE contracts to 25.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 2:01 AM ET
Data refreshes hourly during market hours. Next update: 3:01 AM
Data refreshes hourly during market hours. Next update: 3:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 50 HOLD |
